These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8620462)

  • 1. Inhibition of aromatase activity and growth suppression by 4-methoxy-4-androstene-3,17-dione in an androgen sensitive human prostatic carcinoma cell line.
    Block JL; Block NL; Lokeshwar BL
    Cancer Lett; 1996 Mar; 101(2):143-8. PubMed ID: 8620462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of 4-hydroxy-4-androstene-3,17-dione on androgen metabolism and action in cultured human foreskin fibroblasts.
    Hsiang YH; Berkovitz GD; Brown TR; Migeon CJ; Brodie AM
    J Steroid Biochem; 1987 Jan; 26(1):131-5. PubMed ID: 3821101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aromatase and other inhibitors in breast and prostatic cancer.
    Brodie AM; Banks PK; Inkster SE; Son C; Koos RD
    J Steroid Biochem Mol Biol; 1990 Dec; 37(6):1043-8. PubMed ID: 2285580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth suppression of MCF-7 human breast cancer cells by aromatase inhibitors: a new system for aromatase inhibitor screening.
    Kitawaki J; Kim T; Kanno H; Noguchi T; Yamamoto T; Okada H
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):667-70. PubMed ID: 8476780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aromatase inhibition: 4-hydroxyandrostenedione (4-OHA, CGP 32349) in advanced prostatic cancer.
    Davies JH; Dowsett M; Jacobs S; Coombes RC; Hedley A; Shearer RJ
    Br J Cancer; 1992 Jul; 66(1):139-42. PubMed ID: 1637664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivo.
    Brodie AM; Garrett WM; Hendrickson JR; Tsai-Morris CH; Marcotte PA; Robinson CH
    Steroids; 1981 Dec; 38(6):693-702. PubMed ID: 7336466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of evidence for aromatase in human prostatic tissues: effects of 4-hydroxyandrostenedione and other inhibitors on androgen metabolism.
    Brodie AM; Son C; King DA; Meyer KM; Inkster SE
    Cancer Res; 1989 Dec; 49(23):6551-5. PubMed ID: 2479464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of 2,2-dimethyl-4-hydroxy-4-androstene-3,17-dione as an inhibitor of aromatase.
    Furth PS; Rosenberger J; Marcotte PA; Robinson CH
    J Enzyme Inhib; 1990; 4(2):131-5. PubMed ID: 2098519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of analogues of 4-androstene-3,17-dione as aromatase inhibitors.
    Rowlands MG; Foster AB; Mann J; Pietrzak B; Wilkinson J; Coombes RC
    Steroids; 1987; 49(4-5):371-82. PubMed ID: 3455049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 10-(2-propynyl)-estr-4-ene-3,17-dione (MDL 18,962)--a mechanism-based irreversible inhibitor of aromatase--in cultured human foreskin fibroblasts.
    Kruter RH; Berkovitz GD; Migeon CJ; Brown TR
    J Steroid Biochem; 1987 Aug; 28(2):139-45. PubMed ID: 3626551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aromatase activity in a rat Leydig cell tumor.
    Orczyk GP; Mordes JP; Longcope C
    Endocrinology; 1987 Apr; 120(4):1482-9. PubMed ID: 3030702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line.
    Sonne-Hansen K; Lykkesfeldt AE
    J Steroid Biochem Mol Biol; 2005 Jan; 93(1):25-34. PubMed ID: 15748829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo studies with aromatase inhibitor 4-hydroxy-androstenedione.
    Brodie AM; Wing LY
    Steroids; 1987; 50(1-3):89-103. PubMed ID: 3504069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of the aromatase inhibitor, 4-(phenylthio)-4-androstene-3,17-dione, on dimethylbenz(A)anthracene-induced rat mammary tumors.
    Abul-Hajj YJ
    J Steroid Biochem; 1989; 34(1-6):439-42. PubMed ID: 2516585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatase inhibitors prevent granulosa cell differentiation: an obligatory role for estrogens in luteinizing hormone receptor expression.
    Knecht M; Brodie AM; Catt KJ
    Endocrinology; 1985 Sep; 117(3):1156-61. PubMed ID: 2990868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aromatase inhibition in advanced prostatic cancer: preliminary communication.
    Shearer RJ; Davies JH; Dowsett M; Malone PR; Hedley A; Cunningham D; Coombes RC
    Br J Cancer; 1990 Aug; 62(2):275-6. PubMed ID: 2201397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative studies of aromatase inhibitors in cultured human breast cancer cells.
    MacIndoe JH; Woods GR; Etre LA; Covey DF
    Cancer Res; 1982 Aug; 42(8 Suppl):3378s-3381s. PubMed ID: 7083203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aromatase inhibitors and their potential clinical significance.
    Brodie AM; Wing LY; Goss P; Dowsett M; Coombes RC
    J Steroid Biochem; 1986 Nov; 25(5B):859-65. PubMed ID: 3807367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the aromatase inhibitor 7 alpha-(4'-amino)phenylthio-4-androstene-3,17-dione in MCF-7 human mammary carcinoma cell culture.
    Brueggemeier RW; Katlic NE
    Cancer Res; 1987 Sep; 47(17):4548-51. PubMed ID: 3621153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical significance of 19-hydroxytestosterone in the process of aromatization in human corpus luteum.
    Watanabe S; Tohma Y; Chiba H; Shimizu Y; Saito H; Yanaihara T
    Endocr J; 1994 Aug; 41(4):421-7. PubMed ID: 8528358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.